Evaluation of Tumor Motion Effects On Dose Distribution for Hypofractionated Radiotherapy of Non-Small-Cell Lung Cancer

被引：0
|
作者：
Kang, H.
Yorke, E.
Yang, J.
Chui, C.
Rosenzweig, K.
Amols, H.
机构：
来源：
MEDICAL PHYSICS | 2008年 / 35卷 / 06期
关键词：
D O I：
10.1118/1.2962608
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
TU-EE-A104
引用
收藏
页码：2910 / +
页数：2
相关论文
共 50 条
  • [1] Evaluation of tumor motion effects on dose distribution for hypofractionated intensity-modulated radiotherapy of non-small-cell lung cancer
    Kang, Hyejoo
    Yorke, Ellen D.
    Yang, Jie
    Chui, Chen-Shou
    Rosenzweig, Kenneth E.
    Amols, Howard I.
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2010, 11 (03): : 78 - 89
  • [2] Immune Response on Optimal Timing and Fractionation Dose for Hypofractionated Radiotherapy in Non-Small-Cell Lung Cancer
    Zhao, Xianlan
    Li, Jixi
    Zheng, Linpeng
    Yang, Qiao
    Chen, Xu
    Chen, Xiewan
    Yu, Yongxin
    Li, Feng
    Cui, Jianxiong
    Sun, Jianguo
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [3] POST-OPERATIVE HYPOFRACTIONATED RADIOTHERAPY IN NON-SMALL-CELL LUNG CANCER
    Trotsenko, S. D.
    Solodky, V. A.
    Sotnikov, V. M.
    Panshin, G. A.
    Chkhikvadze, V. D.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : E32 - E33
  • [4] Dose-Limiting Toxicity After Hypofractionated Dose-Escalated Radiotherapy in Non-Small-Cell Lung Cancer
    Cannon, Donald M.
    Mehta, Minesh P.
    Adkison, Jarrod B.
    Khuntia, Deepak
    Traynor, Anne M.
    Tome, Wolfgang A.
    Chappell, Richard J.
    Tolakanahalli, Ranjini
    Mohindra, Pranshu
    Bentzen, Soren M.
    Cannon, George M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (34) : 4343 - U67
  • [5] Outcomes of accelerated hypofractionated radiotherapy in stage I non-small-cell lung cancer
    Yung, T.
    Giuliani, M. E.
    Le, L. W.
    Sun, A.
    Cho, B. C. J.
    Bezjak, A.
    Brade, A.
    Hope, A. J.
    CURRENT ONCOLOGY, 2012, 19 (04) : E264 - E269
  • [6] Hypofractionated radiotherapy for advanced non-small-cell lung cancer: Is the LINAC half full?
    Bogart, JA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) : 765 - 768
  • [7] Dose, volume, and tumor control predictions in primary radiotherapy of non-small-cell lung cancer
    Willner, J
    Baier, K
    Caragiani, E
    Tschammler, A
    Flentje, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (02): : 382 - 389
  • [8] Hypofractionated Intensity-Modulated Radiotherapy for Patients With Non-Small-Cell Lung Cancer
    Pollom, Erqi L.
    Qian, Yushen
    Durkee, Ben Y.
    von Eyben, Rie
    Maxim, Peter G.
    Shultz, David B.
    Gensheimer, Michael
    Diehn, Maximilian
    Loo, Billy W., Jr.
    CLINICAL LUNG CANCER, 2016, 17 (06) : 588 - 594
  • [9] Palliative radiotherapy for non-small-cell lung cancer: Which dose?
    Hoskin, PJ
    CLINICAL ONCOLOGY, 2005, 17 (01) : 59 - 60
  • [10] Clinical evaluation of proton radiotherapy for non-small-cell lung cancer
    Shioyama, Y
    Tokuuye, K
    Okumura, T
    Kagei, K
    Sugahara, S
    Ohara, K
    Akine, Y
    Ishikawa, S
    Satoh, H
    Sekizawa, K
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (01): : 7 - 13
12345